Lineage Cell Therapeutics

LCTX • AMEX • Stock Fundamentals

Lineage Cell Therapeutics is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Brian Culley, with a market cap of $324.1M.

Market Cap$324.1M

Employees75.0

CEOBrian Culley

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026

Next EarningsAug 11, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Lineage Cell Therapeutics

Lineage Cell Therapeutics (LCTX) has a market capitalization of $324.1M and trades on AMEX.

Lineage Cell Therapeutics has approximately 75 employees.